Report suggests FDA may not reauthorize Pfizer COVID vaccine for young kids
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 The US Food and Drug Administration (FDA) has signaled that it might not renew the emergency use authorization (EUA) for Pfizer’s COVID-19 vaccine for children ages 6 months to 4 years old for the upcoming respiratory virus season, which may limit the supply of vaccines for the youngest kids, The Guardian reported yesterday, based on a Centers for Disease Control and Prevention (CDC) email it obtained that the agency sent on August 8 to
